1.Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion.
Taek Sang LEE ; Jae Weon KIM ; Dae Yeon KIM ; Young Tae KIM ; Ki Heon LEE ; Byoung Gie KIM ; D Scott MCMEEKIN
Journal of Korean Medical Science 2010;25(4):552-556
To determine whether radical hysterectomy is necessary in the treatment of endometrial cancer patients with cervical involvement, we reviewed the medical records of women who underwent primary surgical treatment for endometrial carcinoma and selected patients with pathologically proven cervical invasion. Among 133 patients, 62 patients underwent extrafascial hysterectomy (EH) and 71 radical or modified radical hysterectomy (RH). The decision regarding EH or RH was made at the discretion of the attending surgeon. The sensitivity of pre-operative magnetic resonance imaging for cervical invasion was 44.7% (38/85). In RH patients, 10/71 (14.1%) patients had frankly histologic parametrial involvement (PMI). All were stage III or over. Eight of 10 patients had pelvic/paraaortic node metastasis and two showed extrauterine spread. In 74 patients with stage II cancer, RH was performed in 41 and PMI was not seen. Sixty-six (89.2%) patients had adjuvant radiation therapy and there were 3 patients who had developed recurrent disease in the RH group and none in the EH group (Mean follow-up: 51 months). Although these findings cannot conclusively refute or support the necessity of radical hysterectomy in patients with cervical extension, it is noteworthy that the risk of PMI seems to be minimal in patients with a tumor confined to the uterus without evidence of extrauterine spread.
Adult
;
Aged
;
Databases, Factual
;
Endometrial Neoplasms/epidemiology/*pathology/*surgery
;
Female
;
Humans
;
*Hysterectomy/methods
;
Korea/epidemiology
;
Middle Aged
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local/pathology
;
Neoplasm Staging
;
Radiotherapy, Adjuvant
;
Retrospective Studies
;
Treatment Outcome
;
Uterine Cervical Neoplasms/epidemiology/*pathology/*surgery
2.The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
Malcolm D MATTES ; Jennifer C LEE ; Daniel J METZGER ; Hani ASHAMALLA ; Evangelia KATSOULAKIS
Journal of Gynecologic Oncology 2015;26(1):19-24
OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and lymph node dissection. METHODS: Nine hundred seventy-two eligible patients diagnosed between 1998 to 2009 with International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IA-IVA UPSC (n=685) or UCCC (n=287) were identified for analysis. Binomial logistic regression was used to determine risk factors for lymph node metastasis, with the incidence of pelvic and para-aortic lymph node metastases reported for each FIGO primary tumor stage. The Cox proportional hazards regression model was used to determine factors associated with overall survival. RESULTS: FIGO primary tumor stage was the only independent risk factor for lymph node metastasis (p<0.01). The incidence of pelvis-only and para-aortic lymph node involvement according to the FIGO primary tumor stage were as follows: IA (2.3%/3.8%), IB (7.5%/5.2%), IC (22.5%/16.9%), IIA (20.8%/13.2%), IIB (25.7%/14.9%), and III/IV (25.7%/24.3%). Prognostic factors for overall survival included lymph node involvement (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.09 to 1.85; p<0.01), patient age >60 years (HR, 1.70; 95% CI, 1.21 to 2.41; p<0.01), and advanced FIGO primary tumor stage (p<0.01). Tumor grade, histologic subtype, and patient race did not predict for either lymph node metastasis or overall survival. CONCLUSION: There is a high incidence of both pelvic and para-aortic lymph node metastases for FIGO stages IC and above uterine papillary serous and clear cell carcinomas, suggesting a potential role for lymph node-directed therapy for these patients.
Adenocarcinoma, Clear Cell/epidemiology/pathology/*secondary/surgery
;
Adult
;
Aged
;
Aged, 80 and over
;
Aorta, Abdominal
;
Cystadenocarcinoma, Papillary/epidemiology/pathology/*secondary/surgery
;
Cystadenocarcinoma, Serous/epidemiology/pathology/*secondary/surgery
;
Female
;
Humans
;
Incidence
;
Kaplan-Meier Estimate
;
Lymph Node Excision
;
Lymphatic Metastasis
;
Middle Aged
;
Neoplasm Grading
;
Neoplasm Staging
;
Pelvis
;
SEER Program
;
United States/epidemiology
;
Uterine Neoplasms/*epidemiology/pathology/surgery
3.Value of Second Pass in Loop Electrosurgical Excisional Procedure.
Kidong KIM ; Soon Beom KANG ; Hyun Hoon CHUNG ; Tack Sang LEE ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG
Journal of Korean Medical Science 2009;24(1):110-113
The aim of this study was to compare the rate of incomplete resection and treatment outcome of the second-pass technique with those of single-pass technique in loop electrosurgical excisional procedure (LEEP). From 1997 to 2002, 683 women were diagnosed as squamous dysplasia via LEEP in our institution. Age, parity, LEEP technique, grade of lesion, glandular extension, margin status, residual tumor and recurrence were obtained by reviewing medical records. Positive margin was defined as mild dysplasia or higher grade lesions at resection margin of the LEEP specimen. In women who underwent hysterectomy, residual tumor was defined as mild dysplasia or higher grade lesions in hysterectomy specimen. In women who did not underwent hysterectomy, Pap smear more than atypical squamous cells of undetermined significance or biopsy result more than mild dysplasia within two years after LEEP were regarded as cytologic or histologic recurrences, respectively. Treatment failure of LEEP was defined as residual tumor or histologic recurrence. The second-pass technique significantly reduced the endocervical margin positivity (odds ratio [OR], 0.36; 95% confidence interval [CI], 0.21-0.63). However, the second-pass technique did not reduce the treatment failure (OR, 0.62; 95% CI, 0.29-1.32). In conclusion, the second-pass technique markedly reduced the endocervical margin positivity, but did not reduce the treatment failure rate of LEEP.
Adult
;
Cervical Intraepithelial Neoplasia/pathology/*surgery
;
Electrosurgery/*methods
;
Female
;
Humans
;
Hysterectomy
;
Medical Records
;
Middle Aged
;
Neoplasm Recurrence, Local/diagnosis/epidemiology
;
Neoplasm, Residual/diagnosis/epidemiology
;
Odds Ratio
;
Recurrence
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
Uterine Cervical Neoplasms/pathology/*surgery